📰 Ron Menezes News
Ron Menezes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ron Menezes. Real-time updates on events, politics, business and more.
February 27, 2024
Sientra Inc., a troubled maker of aesthetics products, isn’t giving up its goal to make itself look better.On Feb. 12, it filed for Chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware and said it was seeking a buyer.
February 15, 2024
The company has nearly $70 million in debt and thousands of customers in various stages of treatment.
February 13, 2024
IRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company devel...
November 11, 2023
Sientra, Inc. (NASDAQ:SIEN) Q3 2023 Earnings Call Transcript November 9, 2023 Sientra, Inc. misses on earnings expectations. Reported EPS is $-1.31 EPS, expectations were $-0.48. Operator: Good afternoon and welcome to the Sientra Third Quarter 2023 Financial Results Conference Call. My name is Dave. At this time, all participants are in a listen-only mode. After […]
November 11, 2023
Operator: Good afternoon and welcome to the Sientra Third Quarter 2023 Financial Results Conference Call. My name is Dave. At this time, all participants are in a listen-only mode.
November 9, 2023
IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company devel...
October 31, 2023
Sientra Inc (NASDAQ: SIEN) shares are down after the company withdrew its FY23 guidance and reported 
October 30, 2023
IRVINE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a surgical aesthetics company delivering the safest and most innovative solutions for the best outcomes, today
October 30, 2023
IRVINE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company delivering the...
June 12, 2023
Sientra, Inc. (NASDAQ: SIEN) shares rocket 82% as the medical aesthetics company achieves a significant milestone with their AlloX2 Pro Tissue Expander.